3.0.0
6710
2022-12-30T04:18:56Z
2022-12-30T04:18:56Z
House
HR
2022-02-11
117
[Congressional Record Volume 168, Number 28 (Friday, February 11, 2022)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. HERRELL:H.R. 6710.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8. To make laws which shall benecessary and proper for carrying into execution theforegoing powers, and all other powers vested by thisConstitution in the government of the United States, or inany department or officer thereof.[Page H1119]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2022-02-14T18:51:33Z
  - Referred to
2022-02-11T16:00:25Z

- Countering Communist China Act
117
4792
HR
2021-09-03
Referred to the Subcommittee on Energy and Mineral Resources.
  - Related bill
CRS
- 2022-02-14
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2022-02-11
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2022-02-11
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2022-02-11
Introduced in House
IntroReferral
1000
9
Library of Congress
- H001084
Rep. Herrell, Yvette [R-NM-2]
Yvette
Herrell
R
NM
2
N
- B001299
Rep. Banks, Jim [R-IN-3]
Jim
Banks
R
IN
3
2022-02-11
True
- M001180
Rep. McKinley, David B. [R-WV-1]
David
McKinley
R
WV
B.
1
2022-02-11
True
- H001082
Rep. Hern, Kevin [R-OK-1]
Kevin
Hern
R
OK
1
2022-02-11
True
- M001211
Rep. Miller, Mary E. [R-IL-15]
Mary
Miller
R
IL
E.
15
2022-02-11
True
- H001077
Rep. Higgins, Clay [R-LA-3]
Clay
Higgins
R
LA
3
2022-02-11
True
- M001215
Rep. Miller-Meeks, Mariannette [R-IA-2]
Mariannette
Miller-Meeks
R
IA
2
2022-02-11
True
- S001189
Rep. Scott, Austin [R-GA-8]
Austin
Scott
R
GA
8
2022-02-11
True
- D000032
Rep. Donalds, Byron [R-FL-19]
Byron
Donalds
R
FL
19
2022-02-11
True
- C001104
Rep. Cawthorn, Madison [R-NC-11]
Madison
Cawthorn
R
NC
11
2022-02-11
True
- N000190
Rep. Norman, Ralph [R-SC-5]
Ralph
Norman
R
SC
5
2022-02-11
True
- L000266
Rep. LaTurner, Jake [R-KS-2]
Jake
LaTurner
R
KS
2
2022-02-11
True
- K000395
Rep. Keller, Fred [R-PA-12]
Fred
Keller
R
PA
12
2022-02-11
True
- H001067
Rep. Hudson, Richard [R-NC-8]
Richard
Hudson
R
NC
8
2022-02-11
True
- C001039
Rep. Cammack, Kat [R-FL-3]
Kat
Cammack
R
FL
3
2022-02-11
True
- G000552
Rep. Gohmert, Louie [R-TX-1]
Louie
Gohmert
R
TX
1
2022-02-11
True
- M000871
Rep. Mann, Tracey [R-KS-1]
Tracey
Mann
R
KS
1
2022-02-15
False
- B001291
Rep. Babin, Brian [R-TX-36]
Brian
Babin
R
TX
36
2022-02-18
False
- H001053
Rep. Hartzler, Vicky [R-MO-4]
Vicky
Hartzler
R
MO
4
2022-02-22
False
- J000304
Rep. Jackson, Ronny [R-TX-13]
Ronny
Jackson
R
TX
13
2022-03-07
False
- M001195
Rep. Mooney, Alexander X. [R-WV-2]
Alexander
Mooney
R
WV
X.
2
2022-03-24
False
Health
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Emergency medical services and trauma care
- Infectious and parasitic diseases
- Manufacturing
- Trade restrictions
Health
00
2022-02-11
Introduced in House
2022-09-06T15:34:27Z
This bill requires the Food and Drug Administration (FDA) to report to Congress on barriers to the domestic manufacturing of imported active pharmaceutical ingredients, finished drug products, and devices that are critical to public health.
The report must recommend strategies to overcome such barriers. The FDA may, to the extent appropriate, implement the strategies.

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
- Display Title

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
- Official Title as Introduced

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.
Introduced in House
IH
- Introduced in House
2022-02-11T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-117hr6710ih/xml/BILLS-117hr6710ih.xml
2022-02-14
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.